Rhythm to Present at MST Access Investor Conference
Filed with ASX · · 29 pages · English
Rhythm Biosciences Limited on 6ix
In the deck
Earlier from Rhythm Biosciences
- RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial
- FY22 Strategic Update
- Rhythm Betters ColoSTAT Results
- Rhythm Extends ColoSTAT Clinical Trial to Western Australia
- Rhythm Retains ISO13485 Certification
Later from Rhythm Biosciences
- Rhythm Establishes US Entity To Drive US Expansion Strategy
- Non renouneable rights issue prospectus
- Rights Issue Investor Presentation
- Non Renounceable pro rata offer - Completion of despatch
- Initial TGA Regulatory Documentation Submitted
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences